Living Donor Evaluation Framework KDIGO — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Comprehensive evaluation of medical suitability (including projected lifetime ESKD risk from donation), psychosocial assessment, informed consent about short-term surgical risks and long-term renal/cardiovascular consequences, and ensuring voluntary non-coerced decision-making
KDIGO 2017 living donor guideline established a comprehensive risk-based framework: (1) Medical evaluation: projected lifetime ESKD risk (integrating age, eGFR, BMI, BP, family history, ethnicity, sex – the acceptable threshold is typically <1% post-donation ESKD risk); (2) Surgical risk: perioperative mortality ~0.03%, major complications ~2-4%; (3) Long-term outcomes: slight increase in ESKD risk (from ~0.03% to ~0.09% lifetime) and mild BP increase; (4) Psychosocial: voluntary decision, no coercion, understanding of implications; (5) Informed consent: documented discussion of risks, alternatives, and the right to withdraw at any stage.
Reference: KDIGO 2017 – Living Kidney Donor Evaluation Guideline